http://new.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Fri, 14 Aug 2026 03:38:32 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://new.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Intl+Ratings/Clariant+AG+%28CLN%3ASW%29+%28CLZNY%29+PT+Raised+to+CHF13+at+JPMorgan/26923463.html <p>JPMorgan analyst Chetan Udeshi raised the price target on Clariant AG (CLN:SW) (OTC: CLZNY) to CHF13.00 (from CHF9.30) while maintaining a Overweight rating.</p><p>The analyst comments: “We view the late-July Amsterdam court ruling dismissing Shell’s €1.0bn ethylene damages claim against Clariant (CLN) and three other companies as a meaningful de-risking event, removing a key valuation overhang and potentially setting an important precedent given the apparent difficulty for other claimants to evidence and quantify damages (including methodology, market comparability and proof of price impact). Combined with a 2Q26 earnings beat—particularly in Catalysis, where the earnings headwind from Middle East (ME) conflict-related disruption http://www.streetinsider.com/Intl+Ratings/Clariant+AG+%28CLN%3ASW%29+%28CLZNY%29+PT+Raised+to+CHF13+at+JPMorgan/26923463.html Fri, 14 Aug 2026 03:38:32 -0400 CLZNY http://www.streetinsider.com/Analyst+PT+Change/Clariant+AG+%28CLN%3ASW%29+%28CLZNY%29+PT+Raised+to+CHF13+at+JPMorgan/26923463.html <p>JPMorgan analyst Chetan Udeshi raised the price target on Clariant AG (CLN:SW) (OTC: CLZNY) to CHF13.00 (from CHF9.30) while maintaining a Overweight rating.</p><p>The analyst comments: “We view the late-July Amsterdam court ruling dismissing Shell’s €1.0bn ethylene damages claim against Clariant (CLN) and three other companies as a meaningful de-risking event, removing a key valuation overhang and potentially setting an important precedent given the apparent difficulty for other claimants to evidence and quantify damages (including methodology, market comparability and proof of price impact). Combined with a 2Q26 earnings beat—particularly in Catalysis, where the earnings headwind from Middle East (ME) conflict-related disruption http://www.streetinsider.com/Analyst+PT+Change/Clariant+AG+%28CLN%3ASW%29+%28CLZNY%29+PT+Raised+to+CHF13+at+JPMorgan/26923463.html Fri, 14 Aug 2026 03:38:32 -0400 CLZNY http://www.streetinsider.com/Analyst+Comments/Clariant+AG+%28CLN%3ASW%29+%28CLZNY%29+PT+Raised+to+CHF13+at+JPMorgan/26923463.html <p>JPMorgan analyst Chetan Udeshi raised the price target on Clariant AG (CLN:SW) (OTC: CLZNY) to CHF13.00 (from CHF9.30) while maintaining a Overweight rating.</p><p>The analyst comments: “We view the late-July Amsterdam court ruling dismissing Shell’s €1.0bn ethylene damages claim against Clariant (CLN) and three other companies as a meaningful de-risking event, removing a key valuation overhang and potentially setting an important precedent given the apparent difficulty for other claimants to evidence and quantify damages (including methodology, market comparability and proof of price impact). Combined with a 2Q26 earnings beat—particularly in Catalysis, where the earnings headwind from Middle East (ME) conflict-related disruption http://www.streetinsider.com/Analyst+Comments/Clariant+AG+%28CLN%3ASW%29+%28CLZNY%29+PT+Raised+to+CHF13+at+JPMorgan/26923463.html Fri, 14 Aug 2026 03:38:32 -0400 CLZNY http://www.streetinsider.com/Intl+Ratings/Clariant+AG+%28CLN%3ASW%29+%28CLZNY%29+PT+Raised+to+CHF13+at+JPMorgan/26923463.html <p>JPMorgan analyst Chetan Udeshi raised the price target on Clariant AG (CLN:SW) (OTC: CLZNY) to CHF13.00 (from CHF9.30) while maintaining a Overweight rating.</p><p>The analyst comments: “We view the late-July Amsterdam court ruling dismissing Shell’s €1.0bn ethylene damages claim against Clariant (CLN) and three other companies as a meaningful de-risking event, removing a key valuation overhang and potentially setting an important precedent given the apparent difficulty for other claimants to evidence and quantify damages (including methodology, market comparability and proof of price impact). Combined with a 2Q26 earnings beat—particularly in Catalysis, where the earnings headwind from Middle East (ME) conflict-related disruption http://www.streetinsider.com/Intl+Ratings/Clariant+AG+%28CLN%3ASW%29+%28CLZNY%29+PT+Raised+to+CHF13+at+JPMorgan/26923463.html Fri, 14 Aug 2026 03:38:32 -0400 CLZNY http://www.streetinsider.com/Analyst+PT+Change/Clariant+AG+%28CLN%3ASW%29+%28CLZNY%29+PT+Raised+to+CHF13+at+JPMorgan/26923463.html <p>JPMorgan analyst Chetan Udeshi raised the price target on Clariant AG (CLN:SW) (OTC: CLZNY) to CHF13.00 (from CHF9.30) while maintaining a Overweight rating.</p><p>The analyst comments: “We view the late-July Amsterdam court ruling dismissing Shell’s €1.0bn ethylene damages claim against Clariant (CLN) and three other companies as a meaningful de-risking event, removing a key valuation overhang and potentially setting an important precedent given the apparent difficulty for other claimants to evidence and quantify damages (including methodology, market comparability and proof of price impact). Combined with a 2Q26 earnings beat—particularly in Catalysis, where the earnings headwind from Middle East (ME) conflict-related disruption http://www.streetinsider.com/Analyst+PT+Change/Clariant+AG+%28CLN%3ASW%29+%28CLZNY%29+PT+Raised+to+CHF13+at+JPMorgan/26923463.html Fri, 14 Aug 2026 03:38:32 -0400 CLZNY http://www.streetinsider.com/Analyst+Comments/Clariant+AG+%28CLN%3ASW%29+%28CLZNY%29+PT+Raised+to+CHF13+at+JPMorgan/26923463.html <p>JPMorgan analyst Chetan Udeshi raised the price target on Clariant AG (CLN:SW) (OTC: CLZNY) to CHF13.00 (from CHF9.30) while maintaining a Overweight rating.</p><p>The analyst comments: “We view the late-July Amsterdam court ruling dismissing Shell’s €1.0bn ethylene damages claim against Clariant (CLN) and three other companies as a meaningful de-risking event, removing a key valuation overhang and potentially setting an important precedent given the apparent difficulty for other claimants to evidence and quantify damages (including methodology, market comparability and proof of price impact). Combined with a 2Q26 earnings beat—particularly in Catalysis, where the earnings headwind from Middle East (ME) conflict-related disruption http://www.streetinsider.com/Analyst+Comments/Clariant+AG+%28CLN%3ASW%29+%28CLZNY%29+PT+Raised+to+CHF13+at+JPMorgan/26923463.html Fri, 14 Aug 2026 03:38:32 -0400 CLZNY http://www.streetinsider.com/Intl+Ratings/Berenberg+Upgrades+Clariant+AG+%28CLN%3ASW%29+%28CLZNY%29+to+Buy/26907815.html <p>Berenberg analyst Sebastian Bray upgraded Clariant AG (CLN:SW) (OTC: CLZNY) from Hold to Buy with a price target of CHF12.00 (from CHF7.80).</p><p>The analyst comments: “We upgrade our recommendation on Clariant to Buy as we believe that the reduction in litigation risk and the earnings growth that we expect for 2027 should pave the way for share price outperformance.</p><p>Clariant has two advantages compared to the rest of the diversified chemicals sector as we move towards 2027. The first, which has largely – though not fully – been priced into the shares as of the last few weeks, is that the seemingly http://www.streetinsider.com/Intl+Ratings/Berenberg+Upgrades+Clariant+AG+%28CLN%3ASW%29+%28CLZNY%29+to+Buy/26907815.html Wed, 12 Aug 2026 02:54:40 -0400 CLZNY http://www.streetinsider.com/Upgrades/Berenberg+Upgrades+Clariant+AG+%28CLN%3ASW%29+%28CLZNY%29+to+Buy/26907815.html <p>Berenberg analyst Sebastian Bray upgraded Clariant AG (CLN:SW) (OTC: CLZNY) from Hold to Buy with a price target of CHF12.00 (from CHF7.80).</p><p>The analyst comments: “We upgrade our recommendation on Clariant to Buy as we believe that the reduction in litigation risk and the earnings growth that we expect for 2027 should pave the way for share price outperformance.</p><p>Clariant has two advantages compared to the rest of the diversified chemicals sector as we move towards 2027. The first, which has largely – though not fully – been priced into the shares as of the last few weeks, is that the seemingly http://www.streetinsider.com/Upgrades/Berenberg+Upgrades+Clariant+AG+%28CLN%3ASW%29+%28CLZNY%29+to+Buy/26907815.html Wed, 12 Aug 2026 02:54:40 -0400 CLZNY http://www.streetinsider.com/Analyst+Comments/Berenberg+Upgrades+Clariant+AG+%28CLN%3ASW%29+%28CLZNY%29+to+Buy/26907815.html <p>Berenberg analyst Sebastian Bray upgraded Clariant AG (CLN:SW) (OTC: CLZNY) from Hold to Buy with a price target of CHF12.00 (from CHF7.80).</p><p>The analyst comments: “We upgrade our recommendation on Clariant to Buy as we believe that the reduction in litigation risk and the earnings growth that we expect for 2027 should pave the way for share price outperformance.</p><p>Clariant has two advantages compared to the rest of the diversified chemicals sector as we move towards 2027. The first, which has largely – though not fully – been priced into the shares as of the last few weeks, is that the seemingly http://www.streetinsider.com/Analyst+Comments/Berenberg+Upgrades+Clariant+AG+%28CLN%3ASW%29+%28CLZNY%29+to+Buy/26907815.html Wed, 12 Aug 2026 02:54:40 -0400 CLZNY http://www.streetinsider.com/Intl+Ratings/Berenberg+Upgrades+Clariant+AG+%28CLN%3ASW%29+%28CLZNY%29+to+Buy/26907815.html <p>Berenberg analyst Sebastian Bray upgraded Clariant AG (CLN:SW) (OTC: CLZNY) from Hold to Buy with a price target of CHF12.00 (from CHF7.80).</p><p>The analyst comments: “We upgrade our recommendation on Clariant to Buy as we believe that the reduction in litigation risk and the earnings growth that we expect for 2027 should pave the way for share price outperformance.</p><p>Clariant has two advantages compared to the rest of the diversified chemicals sector as we move towards 2027. The first, which has largely – though not fully – been priced into the shares as of the last few weeks, is that the seemingly http://www.streetinsider.com/Intl+Ratings/Berenberg+Upgrades+Clariant+AG+%28CLN%3ASW%29+%28CLZNY%29+to+Buy/26907815.html Wed, 12 Aug 2026 02:54:40 -0400 CLZNY http://www.streetinsider.com/Upgrades/Berenberg+Upgrades+Clariant+AG+%28CLN%3ASW%29+%28CLZNY%29+to+Buy/26907815.html <p>Berenberg analyst Sebastian Bray upgraded Clariant AG (CLN:SW) (OTC: CLZNY) from Hold to Buy with a price target of CHF12.00 (from CHF7.80).</p><p>The analyst comments: “We upgrade our recommendation on Clariant to Buy as we believe that the reduction in litigation risk and the earnings growth that we expect for 2027 should pave the way for share price outperformance.</p><p>Clariant has two advantages compared to the rest of the diversified chemicals sector as we move towards 2027. The first, which has largely – though not fully – been priced into the shares as of the last few weeks, is that the seemingly http://www.streetinsider.com/Upgrades/Berenberg+Upgrades+Clariant+AG+%28CLN%3ASW%29+%28CLZNY%29+to+Buy/26907815.html Wed, 12 Aug 2026 02:54:40 -0400 CLZNY http://www.streetinsider.com/Analyst+Comments/Berenberg+Upgrades+Clariant+AG+%28CLN%3ASW%29+%28CLZNY%29+to+Buy/26907815.html <p>Berenberg analyst Sebastian Bray upgraded Clariant AG (CLN:SW) (OTC: CLZNY) from Hold to Buy with a price target of CHF12.00 (from CHF7.80).</p><p>The analyst comments: “We upgrade our recommendation on Clariant to Buy as we believe that the reduction in litigation risk and the earnings growth that we expect for 2027 should pave the way for share price outperformance.</p><p>Clariant has two advantages compared to the rest of the diversified chemicals sector as we move towards 2027. The first, which has largely – though not fully – been priced into the shares as of the last few weeks, is that the seemingly http://www.streetinsider.com/Analyst+Comments/Berenberg+Upgrades+Clariant+AG+%28CLN%3ASW%29+%28CLZNY%29+to+Buy/26907815.html Wed, 12 Aug 2026 02:54:40 -0400 CLZNY http://www.streetinsider.com/Intl+Ratings/Goldman+Sachs+Upgrades+Clariant+AG+%28CLN%3ASW%29+%28CLZNY%29+to+Buy/26907785.html <p>Goldman Sachs analyst Georgina Fraser upgraded Clariant AG (CLN:SW) (OTC: CLZNY) from Neutral to Buy with a price target of CHF12.00 (from CHF8.50).</p><p>The analyst comments: “The upgrade primarily rests on pent-up catalyst demand – with the largest Middle East-related headwind in the sector having been absorbed – and a potential risk-adjustment of ethylene-cartel litigation by the market following recent news flow. The Amsterdam District Court (29 July) dismissed two live claims against Clariant (Shell for €1bn and the Stichting/Repsol declaratory judgment action) on the grounds that there was no plausible impact on the monthly contract reference price for ethylene. With http://www.streetinsider.com/Intl+Ratings/Goldman+Sachs+Upgrades+Clariant+AG+%28CLN%3ASW%29+%28CLZNY%29+to+Buy/26907785.html Wed, 12 Aug 2026 02:20:50 -0400 CLZNY http://www.streetinsider.com/Upgrades/Goldman+Sachs+Upgrades+Clariant+AG+%28CLN%3ASW%29+%28CLZNY%29+to+Buy/26907785.html <p>Goldman Sachs analyst Georgina Fraser upgraded Clariant AG (CLN:SW) (OTC: CLZNY) from Neutral to Buy with a price target of CHF12.00 (from CHF8.50).</p><p>The analyst comments: “The upgrade primarily rests on pent-up catalyst demand – with the largest Middle East-related headwind in the sector having been absorbed – and a potential risk-adjustment of ethylene-cartel litigation by the market following recent news flow. The Amsterdam District Court (29 July) dismissed two live claims against Clariant (Shell for €1bn and the Stichting/Repsol declaratory judgment action) on the grounds that there was no plausible impact on the monthly contract reference price for ethylene. With http://www.streetinsider.com/Upgrades/Goldman+Sachs+Upgrades+Clariant+AG+%28CLN%3ASW%29+%28CLZNY%29+to+Buy/26907785.html Wed, 12 Aug 2026 02:20:50 -0400 CLZNY http://www.streetinsider.com/Analyst+Comments/Goldman+Sachs+Upgrades+Clariant+AG+%28CLN%3ASW%29+%28CLZNY%29+to+Buy/26907785.html <p>Goldman Sachs analyst Georgina Fraser upgraded Clariant AG (CLN:SW) (OTC: CLZNY) from Neutral to Buy with a price target of CHF12.00 (from CHF8.50).</p><p>The analyst comments: “The upgrade primarily rests on pent-up catalyst demand – with the largest Middle East-related headwind in the sector having been absorbed – and a potential risk-adjustment of ethylene-cartel litigation by the market following recent news flow. The Amsterdam District Court (29 July) dismissed two live claims against Clariant (Shell for €1bn and the Stichting/Repsol declaratory judgment action) on the grounds that there was no plausible impact on the monthly contract reference price for ethylene. With http://www.streetinsider.com/Analyst+Comments/Goldman+Sachs+Upgrades+Clariant+AG+%28CLN%3ASW%29+%28CLZNY%29+to+Buy/26907785.html Wed, 12 Aug 2026 02:20:50 -0400 CLZNY http://www.streetinsider.com/Intl+Ratings/Goldman+Sachs+Upgrades+Clariant+AG+%28CLN%3ASW%29+%28CLZNY%29+to+Buy/26907785.html <p>Goldman Sachs analyst Georgina Fraser upgraded Clariant AG (CLN:SW) (OTC: CLZNY) from Neutral to Buy with a price target of CHF12.00 (from CHF8.50).</p><p>The analyst comments: “The upgrade primarily rests on pent-up catalyst demand – with the largest Middle East-related headwind in the sector having been absorbed – and a potential risk-adjustment of ethylene-cartel litigation by the market following recent news flow. The Amsterdam District Court (29 July) dismissed two live claims against Clariant (Shell for €1bn and the Stichting/Repsol declaratory judgment action) on the grounds that there was no plausible impact on the monthly contract reference price for ethylene. With http://www.streetinsider.com/Intl+Ratings/Goldman+Sachs+Upgrades+Clariant+AG+%28CLN%3ASW%29+%28CLZNY%29+to+Buy/26907785.html Wed, 12 Aug 2026 02:20:50 -0400 CLZNY http://www.streetinsider.com/Upgrades/Goldman+Sachs+Upgrades+Clariant+AG+%28CLN%3ASW%29+%28CLZNY%29+to+Buy/26907785.html <p>Goldman Sachs analyst Georgina Fraser upgraded Clariant AG (CLN:SW) (OTC: CLZNY) from Neutral to Buy with a price target of CHF12.00 (from CHF8.50).</p><p>The analyst comments: “The upgrade primarily rests on pent-up catalyst demand – with the largest Middle East-related headwind in the sector having been absorbed – and a potential risk-adjustment of ethylene-cartel litigation by the market following recent news flow. The Amsterdam District Court (29 July) dismissed two live claims against Clariant (Shell for €1bn and the Stichting/Repsol declaratory judgment action) on the grounds that there was no plausible impact on the monthly contract reference price for ethylene. With http://www.streetinsider.com/Upgrades/Goldman+Sachs+Upgrades+Clariant+AG+%28CLN%3ASW%29+%28CLZNY%29+to+Buy/26907785.html Wed, 12 Aug 2026 02:20:50 -0400 CLZNY http://www.streetinsider.com/Analyst+Comments/Goldman+Sachs+Upgrades+Clariant+AG+%28CLN%3ASW%29+%28CLZNY%29+to+Buy/26907785.html <p>Goldman Sachs analyst Georgina Fraser upgraded Clariant AG (CLN:SW) (OTC: CLZNY) from Neutral to Buy with a price target of CHF12.00 (from CHF8.50).</p><p>The analyst comments: “The upgrade primarily rests on pent-up catalyst demand – with the largest Middle East-related headwind in the sector having been absorbed – and a potential risk-adjustment of ethylene-cartel litigation by the market following recent news flow. The Amsterdam District Court (29 July) dismissed two live claims against Clariant (Shell for €1bn and the Stichting/Repsol declaratory judgment action) on the grounds that there was no plausible impact on the monthly contract reference price for ethylene. With http://www.streetinsider.com/Analyst+Comments/Goldman+Sachs+Upgrades+Clariant+AG+%28CLN%3ASW%29+%28CLZNY%29+to+Buy/26907785.html Wed, 12 Aug 2026 02:20:50 -0400 CLZNY http://www.streetinsider.com/Intl+Ratings/Jefferies+Upgrades+Clariant+AG+%28CLN%3ASW%29+%28CLZNY%29+to+Hold/26876824.html <p>Jefferies analyst Marcus Dunford-Castro upgraded Clariant AG (CLN:SW) (OTC: CLZNY) from Underperform to Hold with a price target of CHF10.20 (from CHF6.00).</p><p>The analyst comments: “We upgrade to HOLD, raising our price target to CHF10.2. The first substantive court test of the ethylene damages has gone in Clariant's favour, with Amsterdam finding insufficient evidence that the infringement influenced the MCP. While ~€10bn of claims remain outstanding, including ~€6.4bn before German courts (that remain free to reach different conclusions), litigation risk, in our view, is meaningfully reduced.</p><p>The significance of the Amsterdam Shell ruling is not that one claim (~€1bn) has been dismissed, http://www.streetinsider.com/Intl+Ratings/Jefferies+Upgrades+Clariant+AG+%28CLN%3ASW%29+%28CLZNY%29+to+Hold/26876824.html Thu, 06 Aug 2026 02:24:51 -0400 CLZNY http://www.streetinsider.com/Upgrades/Jefferies+Upgrades+Clariant+AG+%28CLN%3ASW%29+%28CLZNY%29+to+Hold/26876824.html <p>Jefferies analyst Marcus Dunford-Castro upgraded Clariant AG (CLN:SW) (OTC: CLZNY) from Underperform to Hold with a price target of CHF10.20 (from CHF6.00).</p><p>The analyst comments: “We upgrade to HOLD, raising our price target to CHF10.2. The first substantive court test of the ethylene damages has gone in Clariant's favour, with Amsterdam finding insufficient evidence that the infringement influenced the MCP. While ~€10bn of claims remain outstanding, including ~€6.4bn before German courts (that remain free to reach different conclusions), litigation risk, in our view, is meaningfully reduced.</p><p>The significance of the Amsterdam Shell ruling is not that one claim (~€1bn) has been dismissed, http://www.streetinsider.com/Upgrades/Jefferies+Upgrades+Clariant+AG+%28CLN%3ASW%29+%28CLZNY%29+to+Hold/26876824.html Thu, 06 Aug 2026 02:24:51 -0400 CLZNY http://www.streetinsider.com/Analyst+Comments/Jefferies+Upgrades+Clariant+AG+%28CLN%3ASW%29+%28CLZNY%29+to+Hold/26876824.html <p>Jefferies analyst Marcus Dunford-Castro upgraded Clariant AG (CLN:SW) (OTC: CLZNY) from Underperform to Hold with a price target of CHF10.20 (from CHF6.00).</p><p>The analyst comments: “We upgrade to HOLD, raising our price target to CHF10.2. The first substantive court test of the ethylene damages has gone in Clariant's favour, with Amsterdam finding insufficient evidence that the infringement influenced the MCP. While ~€10bn of claims remain outstanding, including ~€6.4bn before German courts (that remain free to reach different conclusions), litigation risk, in our view, is meaningfully reduced.</p><p>The significance of the Amsterdam Shell ruling is not that one claim (~€1bn) has been dismissed, http://www.streetinsider.com/Analyst+Comments/Jefferies+Upgrades+Clariant+AG+%28CLN%3ASW%29+%28CLZNY%29+to+Hold/26876824.html Thu, 06 Aug 2026 02:24:51 -0400 CLZNY http://www.streetinsider.com/Intl+Ratings/Jefferies+Upgrades+Clariant+AG+%28CLN%3ASW%29+%28CLZNY%29+to+Hold/26876824.html <p>Jefferies analyst Marcus Dunford-Castro upgraded Clariant AG (CLN:SW) (OTC: CLZNY) from Underperform to Hold with a price target of CHF10.20 (from CHF6.00).</p><p>The analyst comments: “We upgrade to HOLD, raising our price target to CHF10.2. The first substantive court test of the ethylene damages has gone in Clariant's favour, with Amsterdam finding insufficient evidence that the infringement influenced the MCP. While ~€10bn of claims remain outstanding, including ~€6.4bn before German courts (that remain free to reach different conclusions), litigation risk, in our view, is meaningfully reduced.</p><p>The significance of the Amsterdam Shell ruling is not that one claim (~€1bn) has been dismissed, http://www.streetinsider.com/Intl+Ratings/Jefferies+Upgrades+Clariant+AG+%28CLN%3ASW%29+%28CLZNY%29+to+Hold/26876824.html Thu, 06 Aug 2026 02:24:51 -0400 CLZNY http://www.streetinsider.com/Upgrades/Jefferies+Upgrades+Clariant+AG+%28CLN%3ASW%29+%28CLZNY%29+to+Hold/26876824.html <p>Jefferies analyst Marcus Dunford-Castro upgraded Clariant AG (CLN:SW) (OTC: CLZNY) from Underperform to Hold with a price target of CHF10.20 (from CHF6.00).</p><p>The analyst comments: “We upgrade to HOLD, raising our price target to CHF10.2. The first substantive court test of the ethylene damages has gone in Clariant's favour, with Amsterdam finding insufficient evidence that the infringement influenced the MCP. While ~€10bn of claims remain outstanding, including ~€6.4bn before German courts (that remain free to reach different conclusions), litigation risk, in our view, is meaningfully reduced.</p><p>The significance of the Amsterdam Shell ruling is not that one claim (~€1bn) has been dismissed, http://www.streetinsider.com/Upgrades/Jefferies+Upgrades+Clariant+AG+%28CLN%3ASW%29+%28CLZNY%29+to+Hold/26876824.html Thu, 06 Aug 2026 02:24:51 -0400 CLZNY http://www.streetinsider.com/Analyst+Comments/Jefferies+Upgrades+Clariant+AG+%28CLN%3ASW%29+%28CLZNY%29+to+Hold/26876824.html <p>Jefferies analyst Marcus Dunford-Castro upgraded Clariant AG (CLN:SW) (OTC: CLZNY) from Underperform to Hold with a price target of CHF10.20 (from CHF6.00).</p><p>The analyst comments: “We upgrade to HOLD, raising our price target to CHF10.2. The first substantive court test of the ethylene damages has gone in Clariant's favour, with Amsterdam finding insufficient evidence that the infringement influenced the MCP. While ~€10bn of claims remain outstanding, including ~€6.4bn before German courts (that remain free to reach different conclusions), litigation risk, in our view, is meaningfully reduced.</p><p>The significance of the Amsterdam Shell ruling is not that one claim (~€1bn) has been dismissed, http://www.streetinsider.com/Analyst+Comments/Jefferies+Upgrades+Clariant+AG+%28CLN%3ASW%29+%28CLZNY%29+to+Hold/26876824.html Thu, 06 Aug 2026 02:24:51 -0400 CLZNY http://www.streetinsider.com/Intl+Ratings/Deutsche+Bank+Upgrades+Clariant+AG+%28CLN%3ASW%29+%28CLZNY%29+to+Buy/26852587.html <p>Deutsche Bank analyst Tristan Lamotte upgraded Clariant AG (CLN:SW) (OTC: CLZNY) from Hold to Buy with a price target of CHF12.60 (from CHF7.50).</p> http://www.streetinsider.com/Intl+Ratings/Deutsche+Bank+Upgrades+Clariant+AG+%28CLN%3ASW%29+%28CLZNY%29+to+Buy/26852587.html Mon, 03 Aug 2026 04:58:24 -0400 CLZNY